Supplementation with human milk oligosaccharides (HMOs) in adulthood may balance the gut microbiome and prevent intestinal inflammation, says a new study that sheds light on the potential mechanisms of action of HMOs.
Food Standards Australia New Zealand (FSANZ) has approved dsm-firmenich’s four human milk oligosaccharides (HMOs), including the mixture of 2’-fucosyllactose (2’-FL) and difucosyllactose (DFL), for use in infant formula products.
Breastfeeding mothers with a higher intake of vegetables, vitamins and metal elements produced more human milk oligosaccharides (HMOs) in their breast milk, according to an observational study funded by Abbott Nutrition R&D Center in Shanghai.
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2'-fucosyllactose (2'FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.